Founded Year
2019Stage
Unattributed | AliveTotal Raised
$800KLast Raised
$800K | 3 yrs agoAbout Cyclone Therapeutics
Cyclone Therapeutics a preclinical-stage drug discovery company spun out of The Scripps Research Institute. The company focuses on products targeting the biology of aging and proteostasis.
Missing: Cyclone Therapeutics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Cyclone Therapeutics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Cyclone Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Cyclone Therapeutics is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
838 items
Cyclone Therapeutics Frequently Asked Questions (FAQ)
When was Cyclone Therapeutics founded?
Cyclone Therapeutics was founded in 2019.
Where is Cyclone Therapeutics's headquarters?
Cyclone Therapeutics's headquarters is located at 19 Morris Avenue, Brooklyn Navy Yard, Brooklyn.
What is Cyclone Therapeutics's latest funding round?
Cyclone Therapeutics's latest funding round is Unattributed.
How much did Cyclone Therapeutics raise?
Cyclone Therapeutics raised a total of $800K.
Who are the investors of Cyclone Therapeutics?
Investors of Cyclone Therapeutics include Scripps Research Institute.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.